![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
19 min
![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
Repurposing rheumatology drugs for COVID-19: Interleukin inhibitors Medicine Matters rheumatology
-
- Medicine
Cristina Mussini discusses the current data on interleukin inhibitors for the treatment of COVID-19 and explores why tocilizumab has been associated with beneficial outcomes in some studies but not others.
Cristina Mussini discusses the current data on interleukin inhibitors for the treatment of COVID-19 and explores why tocilizumab has been associated with beneficial outcomes in some studies but not others.
19 min